Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€15.62

€15.62

-6.880%
-1.16
-6.880%
€10.00

€10.00

 
01.12.21 / Tradegate WKN: A1CTNU / Symbol: ORMP / Name: Oramed / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€10.00
04.11.21
-32.96%
04.12.20
336.31%
Your prediction

Oramed Pharmaceuticals Stock

Heavy losses for Oramed Pharmaceuticals today as the stock fell by -€1.160 (-6.880%).
With 2 Sell predictions and 0 Buy predictions the community sentiment towards the Oramed Pharmaceuticals stock is not clear.
This results in a negative potential of -35.980% based on a current price of €15.62 and a target price of €10.00 for the stock.
For the coming years our community has positive and negative things to say abot the Oramed Pharmaceuticals stock. Criterium "Brand" gathered the most positive votes but regarding "Brand" there were negative voices in the community.

Pros and Cons of Oramed Pharmaceuticals in the next few years

Pros
0
-
Cons
2
Little known brand
2
No uniques
2
Risky balance sheet

Performance of Oramed Pharmaceuticals vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Oramed Pharmaceuticals -6.880% -7.574% -28.018% 412.972% 327.360% 346.286% 168.616%
Enlivex Therapeutics Ltd. -4.030% -16.197% -16.783% -15.603% -32.768% - -
Galmed Pharmaceuticals Ltd. -2.630% 0.000% -8.130% - - - -
Pluristem Therapeutics Inc. -3.170% 2.140% 4.374% -71.253% -59.214% - -

Other discussions about Oramed Pharmaceuticals Stock

New thread Forum